Why Treatment Must Change and What Patients Can Do Antonio C. Bianco, MD Dr. Bianco's long-awaited book is now available from the University of Chicago Press in several formats. A quick scan until I have the time to read it thoroughly brings out some mind blowing but not unexpected r4esearch based concepts – that many… Continue reading Rethinking Hypothyroidism
There are two primary dimensions in follow up treatment for thyroid cancer. The first is focused on preventing and identifying recurrence while the second, often overlooked in the quest to "beat cancer" is supporting your Quality of Life (QoL). Some endocrinologists and other providers may not always be aware of the need to keep TSH… Continue reading TSH Suppression
Serum Thyroglobulin (Tg) is the primary tumor marker measured postoperatively to monitor for recurrence of thyroid cancer. Tg concentrations reflect the mass, or amount, of residual thyroid tissue — remnant or tumor. An unexpected elevated Tg result which is not consistent with clinical findings and history is distressing for the patient and can lead to… Continue reading Falsely Elevated Thyroglobulin – HAMA
Why do I sometimes feel like I’m talking to a brick wall when I see my doctor? As a retired RN and a multi-cancer survivor, I subscribe to Medscape mainly to stay up on new advances in thyroid and other cancers which could affect me. Articles often offer other insights aimed at medical professionals —… Continue reading Talking to a Brick Wall
— From the publisher's press release:New Rochelle, NY, February 18, 2021—Combination therapy with levothyroxine (LT4) and liothyronine (LT3) is widely used to treat hypothyroidism despite clinical trial results not showing a consistent benefit. A new consensus statement, which presents evidence to support the use of LT4/LT3 combinations and to guide future clinical trial development, is… Continue reading New Consensus on Combination Therapy to Treat Hypothyroidism
Thyroid Cancer Advocates 